STOCK PLUMMETS AFTER NOVO NORDISK DEAL COLLAPSE

Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its partnership with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending the company's stock price plummeting by more than fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analy